Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT04503876
Other study ID # RBHP 2019 GODET (Peep Réa)
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date September 12, 2019
Est. completion date October 31, 2021

Study information

Verified date August 2021
Source University Hospital, Clermont-Ferrand
Contact Lise Laclautre
Phone +33 4 73 754963
Email promo_interne_drci@chu-clermontferrand.fr
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

PEEP titration is a recommended during invasive mechanical ventilation of ICU patients. However, little is known about the right way to conduct this titration. PEEP titration can be conducted by a stepwise increase in PEEP level, or following an ARM and a consecutive stepwise decrease in PEEP level. Those 2 methods will be explored in intubated ICU patients either with healthy lung or ARDS lungs. Physiological exploration will include end-expiratory lung volume measurements, driving pressure, compliance and electro-impedance tomography at each PEEP level.


Description:

Management of ICU patients may require the use of ventilatory support requiring tracheal intubation and invasive mechanical ventilation. Any mechanically ventilated patient is exposed to the formation of atelectasis (collapsed pulmonary alveoli), which occurs systematically after endotracheal tube insertion, after any de-recruiting action (tracheal suction, disconnection) or simply if protective ventilation is used, combining small tidal volumes (6 to 8 mL/kg of theoretical ideal body weight - IBW) and an end-expiratory positive pressure (PEEP) that is sometimes insufficient. It is thus proposed to perform alveolar recruitment maneuvers (ARMs), which remove atelectasis by temporarily increasing intrathoracic pressure. To avoid alveolar re-collapse, it is necessary to apply a sufficient level of PEEP. The opening pressure (P) necessary for the re-expansion of a collapsed alveolus is inversely proportional to its radius (r), following Laplace law P = 2.γ/r where γ is the surface tension. The pressure necessary to the re-expansion of a collapsed cell depends on its radius. Amato's team has showed in 2006 that within the same lung, several levels of alveolar aeration and thus several opening pressures coexist. The distribution of pressures was bimodal, with a peak around 30 cmH2O and a second around 40 cmH2O. Consequently, to allow complete re-expansion of atelectasis within a lung, it is necessary to apply a pressure at least equal to 30 cmH2O. The application of insufficient pressures cannot be expected to result in complete re-expansion of the lung, but rather in an increase in aeration of already aerated alveoli (whose radius is larger and whose opening pressure is much lower), what, in turn, can lead to over-distension. This is probably what can happen if the PEEP is increased without any previous ARM. The application of an ARM can also lead to an overdistension phenomenon during a reduced period of time (20 to 30 seconds), contrary to the direct application of a high PEEP which could led to an overdistension lasting a much longer period of time (possibly several hours) and aggravated with each administration of a tidal volume (and thus several times per minute). Chronic lung exposure to overdistension phenomena can induce a disintegration of alveolar collagen fibers (volotrauma), leading to local inflammation (biotrauma) and systemic inflammation by releasing pro-inflammatory molecules (cytokines...) into the bloodstream and led to apoptosis in distant organs (kidney, digestive tract for example). The optimization of mechanical ventilation requires the search for the optimal PEEP: insufficient, it cannot prevent atelectasis formation; too high, it would lead to alveolar overdistension. In current practice, the PEEP is determined arbitrary or following a stepwise titration, either by incremental or decremental steps. To date, scientific literature is not unequivocal concerning the use of ARMs and their safety. Thus, some teams prefer not to use ARMs and usually apply an upward PEEP level. The concepts presented above are valid both in patients with healthy lungs and in patients with "sick" lungs, the archetype and most severe form of which is acute respiratory distress syndrome (ARDS), which is a frequent pathology in ICU (10 to 20% of patients admitted). Its definition is based on the Berlin criteria published in 2012. The morality varies between 30 and 40% depending on the severity of the respiratory impairment. Management of patients suffering from ARDS requires an optimization of oxygenation, which is based first of all on mechanical ventilation, whether invasive or not. Since the ARDS Network study published in 2000 in the New England Journal of Medicine, it has been globally accepted that tidal volumes should be reduced to no more than 6 mL/kg IBW. Ventilatory management is based on concepts of "baby lung" and "open lung". These concepts explain that it is mandatory to consider that the lung volume available for mechanical ventilation is very small compared to the healthy lung volume (baby lung) and that the reduction in tidal volume must be accompanied by adjustments to keep the lung "open", combating the formation of atelectasis by the use of sufficient PEEP and ARMs. Far from this pulmonary pathology, any mechanically ventilated patient, whether in the ICU or operating theatre, must benefit from a protective strategy. Any inadequate adjustment of the ventilation parameters can lead to lung lesions induced by mechanical ventilation (VILI, Ventilator Induced Lung Injuries) and to lesions similar to those observed during ARDS. We therefore propose to explore the impact on pulmonary aeration and ventilatory parameters of two different strategies of PEEP optimization during invasive mechanical ventilation in healthy lungs and ARDS ICU patients. This randomized controlled study would allow us to validate our hypotheses, depending on the respiratory mechanics and patient's pulmonary disease.The final aim of this study is to determine the effects of a strategy based on the application of an ARM followed by decremental PEEP titration, compared to an incremental PEEP strategy without ARM, on pulmonary and ventilatory physio-(patho)-logical parameters in ICU patients.


Recruitment information / eligibility

Status Recruiting
Enrollment 45
Est. completion date October 31, 2021
Est. primary completion date September 12, 2021
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - Patient over 18 years of age - ICU patients with healthy lungs or lungs with Acute Respiratory Distress Syndrome (according to Berlin criteria) under mechanically invasive controlled ventilation (intubation or tracheotomy) in the early phase of admission (< 12h) - Patient deeply sedated (BIS between 30 and 50) and possibly under neuromuscular blocking agents (TOF < 2/4 at the orbicular) in case of inspiratory efforts - Patient hemodynamically stable with an optimized volemia using a monitoring system (see protocol). - Consent to participate - Patient benefiting from a Social Security Insurance Exclusion Criteria: - Refusal to participate to the proposed study - Obese patient with BMI = 35 kg.cm-2 - Significant hemodynamic instability defined as > 20% increase in catecholamine doses during the last hour, despite optimization of blood volume according to a pre-established protocol - Contraindication to the use of the electro-impedance tomography technique - Thoracic lesions - Chest bandages - Pace-maker/Implantable defibrillator - Contraindication to the performance of an alveolar recruitment maneuver - Major Emphysema

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Increasing PEEP setting
End expiratory lung volume and lung aeration measurements will be conducted using electrical impedance tomography and nitrogen washin-washout method. Measurements will be conducted during the last minute of each step.
Decreasing PEEP setting
End expiratory lung volume and lung aeration measurements will be conducted using electrical impedance tomography and nitrogen washin-washout method. Measurements will be conducted during the last minute of each step.

Locations

Country Name City State
France CHU Clermont-Ferrand

Sponsors (1)

Lead Sponsor Collaborator
University Hospital, Clermont-Ferrand

Country where clinical trial is conducted

France, 

Outcome

Type Measure Description Time frame Safety issue
Primary Recruited lung volume at each PEEP level between the 2 strategies (incremental or decremental). : The main endpoint is the difference between the recruited lung volume measured by nitrogen washin-washout method at the end of each PEEP level (5th minute) with the basal value measured at the beginning of the protocol, between decremental and incremental stepwise PEEP titration The last minute of each Peep Step
Secondary Homogeneity of pulmonary aeration Evaluation by using the Electrical Impedance Tomography (EIT) - derived index Center of ventilation (CoV) The last minute of each Peep Step
Secondary Homogeneity of pulmonary aeration Evaluation by using the Global Inhomogeneity index (GI) by electro-impedance tomography (EIT) The last minute of each Peep Step
Secondary Regional impedance variation Evaluation of regional impedance variation (TIV: Tidal Impedance Variation) by EIT Measurement during the last minute of each PEEP step
Secondary Atelectrauma Assessement of atelectrauma (RVD: Regional Ventilation Delay) by EIT Measurement during the last minute of each PEEP step
Secondary Lung volume variations Evaluation of lung volume variations by EIT (EELI : End Expiratory Lung Impedance) Measurement during the last minute of each PEEP step
Secondary Mechanical power delivered Mechanical power delivered By using the formula : Power rs =RR·{?V² ·[1/2 ·ELrs +RR·((1+I:E) / (60·I:E) x Raw ]+?V·PEEP}. (Gattinoni, Intensive Care Medicine 2016) Measurement during the last minute of each PEEP step
Secondary Alveolar strain Alveolar strain as assessed by TV/FRC where TV stands for tidal volume and FRC functional residual capacity. Measurement during the last minute of each PEEP step
Secondary Recruited lung volume Evaluation of recruited lung volumes (Dellamonica, Intensive Care Medicine 2011) Measurement during the last minute of each PEEP step
Secondary Ventilatory dead space Ventilatory dead space = Vd/Vt. Where Vd is the dead space volume and Vt is the tidal volume Measurement during the last minute of each PEEP step
Secondary Ventilatory parameters Evaluation of the compliance = TV / (Pplat - PEEP) where TV stands for tidal volume, Pplat stands for Plateau Pressure and PEEP stands for Positive End-Expiratory Pressure Measurement during the last minute of each PEEP step
Secondary Ventilatory parameters Evaluation of the driving pressure Measurement during the last minute of each PEEP step
Secondary Ventilatory parameters Evaluation of the plateau pressure Measurement during the last minute of each PEEP step
See also
  Status Clinical Trial Phase
Completed NCT04435613 - Clinical and Physiological Assessment of a Nearly Ultra-protective Lung Ventilation Strategy: A Quasi-experimental Preliminary Study in ARDS Patients N/A
Enrolling by invitation NCT05020210 - Effect of Early Treatment With Sivelestat Sodium in ARDS Patients
Completed NCT04468971 - REgulatory T Cell infuSion fOr Lung Injury Due to COVID-19 PnEumonia Phase 1
Completed NCT04505592 - Tenecteplase in Patients With COVID-19 Phase 2
Completed NCT04493242 - Extracellular Vesicle Infusion Treatment for COVID-19 Associated ARDS Phase 2
Withdrawn NCT04909879 - Study of Allogeneic Adipose-Derived Mesenchymal Stem Cells for Non-COVID-19 Acute Respiratory Distress Syndrome Phase 2
Completed NCT02265198 - Relationship of Pulmonary Contusion to Pulmonary Inflammation and Incidence of Acute Respiratory Distress Syndrome N/A
Completed NCT01949272 - Optimization of PEEP for Alveolar Recruitment in ARDS N/A
Not yet recruiting NCT01668368 - Goal Directed Mechanical Ventilation Aimed at Optimal Lung Compliance N/A
Completed NCT01881061 - Lung Sonography in Patients With Acute Respiratory Distress Syndrome in Intensive Care Unit N/A
Completed NCT00808691 - Microcirculation and Oxidative Stress in Critical Ill Patients in Surgical Intensive Care Unit N/A
Completed NCT05035589 - The Effect of Tocilizumab on Procalcitonin and Other Biochemical and Clinical Markers in the Setting of COVID-19 Pneumonia
Recruiting NCT04764032 - Right Ventricular Dysfunction in Ventilated Patients With COVID-19
Completed NCT04556513 - Functional Recovery From Acute Respiratory Distress Syndrome (ARDS) Due to COVID-19: Influence of Socio-Economic Status
Recruiting NCT06036056 - NMR Based Metabolomics Kinetics in ARDS Patients
Recruiting NCT04643691 - Losartan and Spironolactone Treatment for ICU Patients With COVID-19 Suffering From ARDS Phase 2
Completed NCT04395911 - Safety and Efficacy of SCD in AKI or ARDS Patients Associated With COVID-19 Infections N/A
Not yet recruiting NCT05341687 - Prognostic Value of Respiratory System Compliance Under VV-ECMO on 180-day Mortality in COVID-19 ARDS.
Recruiting NCT05056090 - Effect of Prone Positioning on Mortality in Patients With Mild to Moderate Acute Respiratory Distress Syndrome. N/A
Recruiting NCT04694742 - Ventilatory Efficiency in Critically Ill COVID-19 Patients